# Can Dipyridamole Induce Protection Against Ischemia and Reperfusion Injury in Patients Undergoing Elective Coronary Artery Bypass Grafting (CABG)?

> **NCT01295567** · PHASE4 · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 95 (actual)

## Conditions studied

- Cardiovascular Disease
- Ischemic Heart Disease

## Interventions

- **DRUG:** Dipyridamole
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01295567
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2012-02
- **Final completion:** 2012-09
- **Target enrollment:** 95 (ACTUAL)
- **Last updated:** 2013-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01295567

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01295567, "Can Dipyridamole Induce Protection Against Ischemia and Reperfusion Injury in Patients Undergoing Elective Coronary Artery Bypass Grafting (CABG)?". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01295567. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*